Axsome Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RTW INVESTMENTS, LP | 02/14/2025 | 4.05 M | $342.79 M | -3.30% | 8.42% |
VANGUARD GROUP INC | 02/11/2025 | 3.90 M | $330.19 M | -2.32% | 8.11% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.53 M | $298.96 M | 3.97% | 7.34% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 02/14/2025 | 1.47 M | $124.29 M | -37.76% | 3.05% |
BVF INC/IL | 02/14/2025 | 1.39 M | $117.44 M | 32.70% | 2.88% |
FMR LLC | 02/13/2025 | 1.00 M | $84.65 M | -8.05% | 2.08% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.00 M | $84.61 M | 0.00% | 2.08% |
MACQUARIE GROUP LTD | 02/14/2025 | 964,047 | $81.57 M | -3.14% | 2.00% |
STATE STREET CORP | 02/14/2025 | 947,251 | $80.15 M | 3.32% | 1.97% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 912,538 | $77.23 M | 0.45% | 1.90% |
EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 828,711 | $70.12 M | 0.10% | 1.72% |
ALETHEA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 734,317 | $62.13 M | -0.57% | 1.53% |
INVESCO LTD. | 02/13/2025 | 692,464 | $58.59 M | 10.76% | 1.44% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 673,157 | $56.96 M | -9.37% | 1.40% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 664,074 | $56.19 M | -15.17% | 1.38% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 644,785 | $54.56 M | 3.15% | 1.34% |
LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 537,669 | $45.49 M | 525.69% | 1.12% |
SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 491,726 | $41.60 M | 29.56% | 1.02% |
02/14/2025 | 470,000 | $39.77 M | 100.00% | 0.98% | |
PFM HEALTH SCIENCES, LP | 02/14/2025 | 467,427 | $39.55 M | 0.00% | 0.97% |
WOODLINE PARTNERS LP | 02/14/2025 | 408,441 | $34.56 M | 36.80% | 0.85% |
NORGES BANK | 02/12/2025 | 403,026 | $34.10 M | 100.00% | 0.84% |
JANE STREET GROUP, LLC | 02/14/2025 | 395,400 | $33.45 M | 245.33% | 0.82% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 391,000 | $33.08 M | 22.11% | 0.81% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 347,900 | $29.44 M | 38.77% | 0.72% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 328,034 | $27.75 M | 1.69% | 0.68% |
CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 325,000 | $27.50 M | -18.75% | 0.68% |
LOOMIS SAYLES & CO L P | 02/12/2025 | 290,111 | $24.55 M | -2.84% | 0.60% |
TRI LOCUM PARTNERS LP | 02/14/2025 | 249,769 | $21.13 M | 172.31% | 0.52% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 221,202 | $18.72 M | 118.10% | 0.46% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 220,000 | $18.61 M | 100.00% | 0.46% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 217,567 | $18.41 M | -40.00% | 0.45% |
PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 207,065 | $17.52 M | 6,002.71% | 0.43% |
JPMORGAN CHASE & CO | 02/12/2025 | 201,902 | $17.08 M | -4.81% | 0.42% |
FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 192,146 | $16.26 M | -24.74% | 0.40% |
AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 188,000 | $15.91 M | -36.51% | 0.39% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 185,661 | $15.71 M | 1,251.93% | 0.39% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 185,138 | $15.66 M | -65.88% | 0.38% |
FRANKLIN RESOURCES INC | 02/12/2025 | 182,290 | $15.42 M | 13.55% | 0.38% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 181,213 | $15.33 M | 191.49% | 0.38% |
CHECKPOINT CAPITAL L.P. | 02/14/2025 | 174,769 | $14.79 M | -16.63% | 0.36% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 174,586 | $14.77 M | 100.00% | 0.36% |
MAN GROUP PLC | 02/14/2025 | 163,388 | $13.82 M | 100.00% | 0.34% |
JANE STREET GROUP, LLC | 02/14/2025 | 160,400 | $13.57 M | 48.11% | 0.33% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 155,911 | $13.19 M | 413.37% | 0.32% |
UBS GROUP AG | 02/14/2025 | 147,347 | $12.47 M | 208.50% | 0.31% |
HSBC HOLDINGS PLC | 02/14/2025 | 136,785 | $11.57 M | -0.20% | 0.28% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 134,550 | $11.38 M | -1.39% | 0.28% |
US BANCORP \DE\ | 02/05/2025 | 131,019 | $11.09 M | -1.58% | 0.27% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 128,900 | $10.91 M | 268.29% | 0.27% |
Axsome Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 371 institutional investors and hedge funds held shares of Axsome Therapeutics, Inc.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 4.05 M
VANGUARD GROUP INC: 3.9 M
BlackRock Funding, Inc. /DE: 3.53 M
Fairmount Funds Management LLC: 1.47 M
BVF INC/IL: 1.39 M
FMR LLC: 1 M
77.27% of Axsome Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 45.20 M shares in the last 24 months. This purchase volume represents approximately $3.85 B in transactions.